SCHEMBL9681571

SCHEMBL9681571

O=C(O)c1ccc2c(c1)Sc1ccccc1CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 5/20 0.54
SRD5A1 P18405 4/20 0.54
ALDH1A1 P00352 4/20 0.47
GRM1 Q13255 2/20 0.42
GRM5 P41594 1/20 0.42
PLEC Q15149 1/20 0.42
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 1/20 0.40
NOTUM Q6P988 1/20 0.40
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.39
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
TTR P02766 1/20 0.39
RARB P10826 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27794501 0.90 SRD5A2 (0.58) SRD5A2SRD5A1ALDH1A1GRM1GRM5
SCHEMBL11010368 0.85 HSD17B3 (0.48) SRD5A2SRD5A1ALDH1A1LMNANOTUM
SCHEMBL9778275 0.81 MAPT (0.46) SRD5A2SRD5A1ALDH1A1GRM1KDM4E
SCHEMBL11015563 0.81 ALDH1A1 (0.42) SRD5A2SRD5A1ALDH1A1GRM1KDM4E
SCHEMBL11096052 0.81 AKR1C3 (0.43) SRD5A2SRD5A1ALDH1A1NOTUMPOLB
SCHEMBL10502889 0.81 ALDH1A1 (0.62) SRD5A2SRD5A1ALDH1A1GRM1KDM4E
SCHEMBL15846800 0.80 SRD5A2 (0.58) SRD5A2SRD5A1ALDH1A1GRM1GRM5
SCHEMBL11098487 0.79 ALDH1A1 (0.41) SRD5A2SRD5A1ALDH1A1PLECHPGD
SCHEMBL11009216 0.79 SRD5A2 (0.40) SRD5A2SRD5A1ALDH1A1GRM1GRM5
SCHEMBL30944690 0.78 PLEC (0.51) SRD5A2PLECKDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0463636-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1992-01-02 EP claimed
EP-0166257-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1986-01-02 EP claimed
US-4536507-A ANTIASTHMA AGENTS MERCK & CO., INC. (US) 1985-08-20 US claimed
EP-0011067-B1 PROSTAGLANDIN ANTAGONISTS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS MERCK & CO. INC. (US) 1982-04-21 EP claimed
EP-0463636-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1992-01-02 EP disclosed
US-5036067-A Enzyme inhibotors MERCK & CO., INC. (US) 1991-07-30 US disclosed
EP-0166257-A2 Cardiovascular composition MERCK FROSST CANADA INC. (CA) 1986-01-02 EP disclosed
US-4558037-A A DIBENZOTHIEPIN COMPOUND AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR MERCK & CO., INC. (US) 1985-12-10 US disclosed
US-4536507-A ANTIASTHMA AGENTS MERCK & CO., INC. (US) 1985-08-20 US disclosed
EP-0029587-B1 3-HYDROXYMETHYLDIBENZO(B,F)THIEPINS AND DIBENZO(B,F)THIEPIN-3-CARBOXALDEHYDES AS PROSTAGLANDIN ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS MERCK SHARP & DOHME (I.A.) CORP. (US) 1984-06-13 EP disclosed
US-4394515-A 10,11-Dihydro-11-oxodibenzo[b,f]thiepin compounds MERCK & CO., INC. (US) 1983-07-19 US disclosed
EP-0011067-B1 PROSTAGLANDIN ANTAGONISTS, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS MERCK & CO. INC. (US) 1982-04-21 EP disclosed
EP-0029587-A1 3-Hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions MERCK SHARP & DOHME (I.A.) CORP. (US) 1981-06-03 EP disclosed
US-4237160-A 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists MERCK SHARP & DOHME (I.A.) CORP. (US) 1980-12-02 US disclosed
EP-0011067-A1 Prostaglandin antagonists, their production and their pharmaceutical compositions MERCK & CO. INC. (US) 1980-05-28 EP disclosed
EP-0000978-A1 7-and 8-substituted -10,11-dihydro-11-oxodibenzo (b,f) thiepin derivatives, their production and their parmaceutical compositions MERCK & CO. INC. (US) 1979-03-07 EP disclosed